Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/26/2003WO2002059354A3 Polynucleotides for use as tags and tag complements, manufacture and use thereof
06/26/2003WO2002055738A3 Molecules for disease detection and treatment
06/26/2003WO2002055701A3 Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
06/26/2003WO2002048332A3 Recombinant phytases and uses thereof
06/26/2003WO2002046385A3 Enzymes
06/26/2003WO2002044406A3 Projection against mycobacterial infections
06/26/2003WO2002042418A3 3-hydroxypropionic acid and other organic compounds
06/26/2003WO2002032378A9 Fusion cells and cytokine compositions for treatment of disease
06/26/2003WO2002024956A3 Genetic markers for tumors
06/26/2003WO2002018608A3 Methods for enhancing the efficacy of cancer therapy
06/26/2003WO2002016944A3 Synthetic nucleic acid molecule compositions and methods of preparation
06/26/2003WO2002016597A3 Lipid metabolism enzymes
06/26/2003WO2002016423A3 PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+/H+ ANTIPORTERS
06/26/2003WO2002016412A3 Binding polypeptides for b lymphocyte stimulator protein (blys)
06/26/2003WO2002014551B1 Bioluminescent methods for direct visual detection of environmental compounds
06/26/2003WO2002010398A3 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
06/26/2003WO2002006529A3 Detection and treatment of polycystic kidney disease
06/26/2003WO2002006525A3 Obesity associated biallelic marker maps
06/26/2003WO2002006327A3 A method for prognosing cancer and the proteins involved
06/26/2003WO2002004493A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
06/26/2003WO2001090154A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
06/26/2003WO2001057273A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
06/26/2003US20030121074 Plant XRCC3 genes and methods of use
06/26/2003US20030121073 Use of acetoacetyl-CoA thiolase for identifying new fungicidally active substances
06/26/2003US20030121070 Genes for modifying plant traits IV
06/26/2003US20030121069 Disruption of the phosphodiesterase 10 gene
06/26/2003US20030121068 Vector encoding suicide and marker constructs
06/26/2003US20030121067 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
06/26/2003US20030121066 Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptions
06/26/2003US20030121065 Polyfunctional base sequence and artificial gene containing the same
06/26/2003US20030121063 Compositions and methods of use of mammalian retrotransposons
06/26/2003US20030121062 Transgenic organism
06/26/2003US20030120429 Method and system for faster and more sensitive homology searching
06/26/2003US20030120428 Prediction method of the effect of radiotherapy for cancer patients
06/26/2003US20030120062 Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix
06/26/2003US20030120060 Induce immunology response; generating neutralizing antibodies
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030120058 Polypeptides; proteolysis splitting; antitumor agents
06/26/2003US20030120055 Caspase activation; antiinflammatory agents; controlling apoptosis
06/26/2003US20030120054 Modified Cry3A toxins and nucleic acid sequences coding therefor
06/26/2003US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid
06/26/2003US20030120050 Modified internucleoside linkages (ii)
06/26/2003US20030120045 Immobilization onto polyoxyethylene glycol
06/26/2003US20030120043 Tumor necrosis factor receptor-associated factors
06/26/2003US20030120038 Inhibitor of vascular endothelial cell growth factor
06/26/2003US20030119891 Polylactam oligomers of N-methyl-2-carboxy-4-imidazole, N-methyl-2-carboxy-4-aminopyrrole modified by 4-aminobutyric acid, 3-amino-propionic acid and 3-(dimethylamino)propylamine binding specifically to the cyclogenase 2 gene
06/26/2003US20030119778 Novel gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof
06/26/2003US20030119777 Oligoribonucleotides and ribonucleases for cleaving RNA
06/26/2003US20030119776 Synthetic oligonucleotide sequence of 2 to 10 bases; treating autoimmune encephalomyelitis, cancer, and graft rejection, tissue rejection or cell rejection.
06/26/2003US20030119774 Compositions and methods for stimulating an immune response
06/26/2003US20030119770 Recombinant lentiviral vectors containing a therapeutic gene of interest fused in-frame with an intercellular trafficking gene for the global delivery of therapeutic proteins in nondividing cells.
06/26/2003US20030119769 Antisense oligonucleotide modulation of raf gene expression
06/26/2003US20030119768 Reducing toxicity by treating the oligonucleotide in multimeric aggregate form to convert all of it to a monomeric form and to prevent the formation of aggregates before administration
06/26/2003US20030119767 Antisense modulation of NOD1 expression
06/26/2003US20030119766 Antisense modulation of apolipoprotein (A) expression
06/26/2003US20030119765 MDM2-specific antisense oligonucleotides
06/26/2003US20030119764 Analog is incorporated by a polymerase into an RNA copy of a genomic nucleic acid encoding the virus, and replaces a first natural occurring nucleotide having a first complementary nucleotide
06/26/2003US20030119742 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587,10183, 10550, 12680, 17921, 32248, 60489 or 93804
06/26/2003US20030119740 Compositions and methods for the diagnosis, prevention and treatment of tumor progression
06/26/2003US20030119737 Human immune response proteins
06/26/2003US20030119733 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
06/26/2003US20030119729 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
06/26/2003US20030119726 P-glycoproteins and uses thereof
06/26/2003US20030119725 Internalization by a broad host cell spectrum; delivery of diagnostics and therapeutics
06/26/2003US20030119724 Contain a hepatic ligand to direct an oligomer or "payload" to a hepatocyte intracellularly via a receptor-mediated, ligand-directed pathway; solid phase synthesis
06/26/2003US20030119717 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
06/26/2003US20030119690 Multiply-substituted protease variants
06/26/2003US20030119192 Complementing cell lines
06/26/2003US20030119191 Compositions and methods for helper-free production of recombinant adeno-associated viruses
06/26/2003US20030119190 Genetic tagging strategy for inducing and identifying mutations in a genomic sequence
06/26/2003US20030119188 Novel compounds
06/26/2003US20030119187 Antigen presenting cells, method for their preparation and their use for cancer vaccines
06/26/2003US20030119182 Immunotherapy; genetic engineering; anticancer agents
06/26/2003US20030119178 DNA chip and its preparation
06/26/2003US20030119170 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
06/26/2003US20030119169 Isolated polypeptides; controlling apoptosis
06/26/2003US20030119168 Diagnosis of anticancer agents using nucleic acids
06/26/2003US20030119167 Cellulase preparation comprising an endoglucanase enzyme
06/26/2003US20030119166 Genetic engineered protein
06/26/2003US20030119165 Plant transcription factors
06/26/2003US20030119160 Drug design, screening; computer analyzing
06/26/2003US20030119159 Aptamer capable of specifically adsorbing to Verotoxin-1 and method for obtaining the aptamer
06/26/2003US20030119158 Polynucleotide compositions encoding broad-spectrum delta endotoxins
06/26/2003US20030119154 Process for the preparation of L-amino acids using a gene encoding 6-phosphogluconate dehydrogenase
06/26/2003US20030119153 Biosynthesis using enterobacter or serratia which increase enzyme activity; citrate synthase, phosphoenolpyruvate carboxylase and glutamate dehydrogenase
06/26/2003US20030119151 Fermenting a microorganism of the Enterobacteriaceae family in which the nucleotide sequence which codes for the hns gene is enhanced and a DNA binding protein is formed; biosynthesis; use as feed additives
06/26/2003US20030119150 Composition and method for hot start nucleic acid amplification
06/26/2003US20030119149 Fusion protein capable of forming a trimer; nonimmunogenic; modulates signaling of tumor necrosis family receptors
06/26/2003US20030119148 Amino-terminally truncated rantes as chemokine antagonists
06/26/2003US20030119146 Novel nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119107 Prevent aggregation of embryos stem cells; controlling by encapsulation
06/26/2003US20030119106 Fusion proteins; binding to antibodies
06/26/2003US20030119104 Genetic engineered artificial chromosomes in plants, animals
06/26/2003US20030119103 Fusion proteins; binding to antibodies
06/26/2003US20030119101 Bactericides, fungicides; transporter proteins
06/26/2003US20030119099 Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof
06/26/2003US20030119098 Plant extract; hybrid nucleic acids; genetic engineering; polymerase chain reactions cycles
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
1 ... 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 ... 4023